Peter Bloch

Peter Bloch

Director/Board Member bei INNOCAN PHARMA CORPORATION

Vermögen: 16 250 $ am 31.03.2024

64 Jahre
Health Technology
Utilities
Producer Manufacturing

Profil

Peter David Bloch was the founder of Tribute Pharmaceuticals, Inc. founded in 2005, where he held the position of Chief Financial Officer.
Currently, he is the Chief Executive Officer at Bionik Laboratories, Inc. since 2011, Chief Executive Officer at Bresotec, Inc., Chief Executive Officer at Wembley Advisors Corp.
since 2018, Director at Hb Agri Products, Inc. since 2014, President, Treasurer & Director at Bionik Mergerco, Inc., Director at InnoCan Pharma Corp.
since 2020, and Chief Financial Officer at Ontario Energy Savings Corp.
He previously held positions as Director at Environmental Solutions Worldwide, Inc. from 2010 to 2011, Director at Walmer Capital Corp.
in 2011, Director at Bionik Laboratories Corp.
from 2012 to 2018, Director at EnerSpar Corp., Chief Financial Officer at Energy Savings Income Fund from 2008 to 2009, Chief Financial Officer & VP-Administration at Gennum Corp.
from 2000 to 2005, Chief Financial Officer at Just Energy (U.S.) Corp.
in 2009, Chief Financial Officer at Just Energy Group, Inc. from 2007 to 2009, and Partner at Guarden Capital, Inc. in 2011.
He also held the position of Chief Executive & Financial Officer at Sanofi Canada, Inc. He received his undergraduate degree from the University of Cape Town in 1982.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
25.03.2024 72 222 ( 0,03% ) 16 250 $ 31.03.2024

Aktive Positionen von Peter Bloch

UnternehmenPositionBeginn
INNOCAN PHARMA CORPORATION Director/Board Member 22.01.2020
Bresotec, Inc. Chief Executive Officer -
President -
Hb Agri Products, Inc. Director/Board Member 01.02.2014
Director of Finance/CFO -
Chief Executive Officer 01.01.2011
Wembley Advisors Corp. Chief Executive Officer 01.01.2018
Alle aktiven Positionen von Peter Bloch

Ehemalige bekannte Positionen von Peter Bloch

UnternehmenPositionEnde
BIONIK LABORATORIES CORP. Chief Executive Officer 01.09.2017
ENVIRONMENTAL SOLUTIONS WORLDWIDE, INC. Director/Board Member 04.03.2011
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Peter Bloch im Detail an

Ausbildung von Peter Bloch

University of Cape Town Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Peter Bloch im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

19

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
ENVIRONMENTAL SOLUTIONS WORLDWIDE, INC.

Producer Manufacturing

BIONIK LABORATORIES CORP.

Health Technology

INNOCAN PHARMA CORPORATION

Health Technology

Private Unternehmen15
Energy Savings Income Fund

Miscellaneous

Electronic Technology

Finance

Utilities

Utilities

Utilities

Commercial Services

Health Technology

Health Technology

Hb Agri Products, Inc.

Health Technology

Health Technology

Bresotec, Inc.

Non-Energy Minerals

Wembley Advisors Corp.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Peter Bloch